Obesity, Morbid
357
66
85
171
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
24 trials with published results (7%)
Research Maturity
171 completed trials (48% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.6%
13 terminated out of 357 trials
92.9%
+6.4% vs benchmark
5%
18 trials in Phase 3/4
14%
24 of 171 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 171 completed trials
Clinical Trials (357)
Impact of MBS on Body Composition, Basal Metabolic Rates and Muscle Functions in Morbid Obese Patients
Responsive Neurostimulation For Loss Of Control Eating
Flow-Controlled vs Volume-Controlled Ventilation in Morbidly Obese Patients Undergoing Laparoscopic Bariatric Surgery
Investigating Metabolic, Brain, and Cognitive Alterations Through Bariatric Surgery
Bariatric Surgery and Pharmacokinetics of Hydrochlorothiazide
Bariatric Surgery and Pharmacokinetics of Gabapentin
Bariatric Surgery and Pharmacokinetics of Candesartan
Bariatric Surgery and Pharmacokinetics of Fluoxetine
Bariatric Surgery and Pharmacokinetics of Irbesartan
Bariatric Surgery and Pharmacokinetics of Chlorprothixene
Bariatric Surgery and Pharmacokinetics of Enalapril
Bariatric Surgery and Pharmacokinetics of Apixaban
Bariatric Surgery and Pharmacokinetics of Ibuprofen
Bariatric Surgery and Pharmacokinetics of Lercanidipine
Bariatric Surgery and Pharmacokinetics of Ramipril
Bariatric Surgery and Pharmacokinetics of Quetiapine
Trans-nasal Endoscopy for Bariatric Patients
Evaluation of Bariatric Endoscopic Antral Myotomy (BEAM) as a Treatment for Obesity
Traxi Panniculus Retractor for Cesarean Delivery
Obesity Cohort : Medical Follow-up of Severe or Morbid Obese Patients Undergoing Bariatric Surgery